Met Life Investment Management, LLC Immunity Bio, Inc. Transaction History

Met Life Investment Management, LLC

  • $18 Billion
  • Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 89,393 shares of IBRX stock, worth $242,255. This represents 0.0% of its overall portfolio holdings.

Number of Shares
89,393
Previous 62,365 43.34%
Holding current value
$242,255
Previous $231,000 1.3%
% of portfolio
0.0%
Previous 0.0%

Shares

39 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$2.56 - $6.17 $69,191 - $166,762
27,028 Added 43.34%
89,393 $228,000
Q3 2024

Nov 13, 2024
SELL
$3.32 - $6.7 $66,160 - $133,517
-19,928 Reduced 24.22%
62,365 $231,000
Q2 2024

Aug 13, 2024
BUY
$4.82 - $9.15 $64,809 - $123,030
13,446 Added 19.53%
82,293 $520,000
Q1 2024

May 14, 2024
BUY
$3.23 - $6.17 $222,375 - $424,785
68,847 New
68,847 $369,000
Q4 2023

Feb 14, 2024
BUY
$1.25 - $5.21 $15,431 - $64,317
12,345 Added 21.11%
70,824 $355,000
Q3 2023

May 09, 2024
BUY
$1.29 - $3.1 $53,642 - $128,907
41,583 Added 246.11%
58,479 $98,000
Q2 2023

Apr 29, 2024
BUY
$1.53 - $6.41 $89,472 - $374,850
58,479 New
58,479 $162,000
Q2 2023

Aug 10, 2023
BUY
$1.53 - $6.41 $63,621 - $266,547
41,583 Added 246.11%
58,479 $162,000
Q1 2023

May 09, 2024
BUY
$1.35 - $4.78 $22,809 - $80,762
16,896 New
16,896 $30.8 Million
Q1 2023

May 15, 2023
SELL
$1.35 - $4.78 $36,670 - $129,839
-27,163 Reduced 61.65%
16,896 $30,000
Q4 2022

Jun 14, 2023
BUY
$4.35 - $6.77 $118,159 - $183,893
27,163 Added 160.77%
44,059 $223,000
Q3 2022

May 10, 2024
BUY
$3.65 - $6.43 $67,357 - $118,659
18,454 Added 72.07%
44,059 $218,000
Q3 2022

Jun 14, 2023
BUY
$3.65 - $6.43 $99,144 - $174,658
27,163 Added 160.77%
44,059 $218,000
Q3 2022

Mar 22, 2023
BUY
$3.65 - $6.43 $67,357 - $118,659
18,454 Added 72.07%
44,059 $218,000
Q3 2022

Nov 14, 2022
BUY
$3.65 - $6.43 $67,357 - $118,659
18,454 Added 72.07%
44,059 $219,000
Q2 2022

May 10, 2024
SELL
$2.68 - $6.14 $20,510 - $46,989
-7,653 Reduced 23.01%
25,605 $95,000
Q2 2022

Jun 20, 2023
BUY
$2.68 - $6.14 $23,340 - $53,473
8,709 Added 51.54%
25,605 $95,000
Q2 2022

Mar 22, 2023
SELL
$2.68 - $6.14 $20,510 - $46,989
-7,653 Reduced 23.01%
25,605 $95,000
Q2 2022

Aug 11, 2022
SELL
$2.68 - $6.14 $20,510 - $46,989
-7,653 Reduced 23.01%
25,605 $95,000
Q1 2022

May 10, 2024
BUY
$5.05 - $7.53 $167,952 - $250,432
33,258 New
33,258 $186,000
Q1 2022

Jun 20, 2023
BUY
$5.05 - $7.53 $82,628 - $123,205
16,362 Added 96.84%
33,258 $186,000
Q1 2022

Mar 22, 2023
BUY
$5.05 - $7.53 $37,253 - $55,548
7,377 Added 28.5%
33,258 $186,000
Q1 2022

May 12, 2022
BUY
$5.05 - $7.53 $37,253 - $55,548
7,377 Added 28.5%
33,258 $187,000
Q4 2021

May 17, 2024
BUY
$5.67 - $10.18 $52,334 - $93,961
9,230 Added 55.43%
25,881 $157,000
Q4 2021

Jun 21, 2023
BUY
$5.67 - $10.18 $50,944 - $91,467
8,985 Added 53.18%
25,881 $157,000
Q4 2021

Mar 22, 2023
BUY
$5.67 - $10.18 $52,334 - $93,961
9,230 Added 55.43%
25,881 $157,000
Q4 2021

Feb 15, 2022
BUY
$5.67 - $10.18 $52,334 - $93,961
9,230 Added 55.43%
25,881 $157,000
Q3 2021

May 17, 2024
SELL
$9.17 - $14.24 $77,312 - $120,057
-8,431 Reduced 33.61%
16,651 $162,000
Q3 2021

Jun 21, 2023
SELL
$9.17 - $14.24 $2,246 - $3,488
-245 Reduced 1.45%
16,651 $162,000
Q3 2021

Mar 22, 2023
SELL
$9.17 - $14.24 $77,312 - $120,057
-8,431 Reduced 33.61%
16,651 $162,000
Q3 2021

Nov 15, 2021
SELL
$9.17 - $14.24 $77,312 - $120,057
-8,431 Reduced 33.61%
16,651 $162,000
Q2 2021

May 17, 2024
BUY
$13.41 - $22.4 $146,584 - $244,854
10,931 Added 77.25%
25,082 $358,000
Q2 2021

Jun 21, 2023
BUY
$13.41 - $22.4 $109,774 - $183,366
8,186 Added 48.45%
25,082 $358,000
Q2 2021

Mar 22, 2023
BUY
$13.41 - $22.4 $146,584 - $244,854
10,931 Added 77.25%
25,082 $358,000
Q2 2021

Aug 16, 2021
BUY
$13.41 - $22.4 $146,584 - $244,854
10,931 Added 77.25%
25,082 $358,000
Q1 2021

May 17, 2024
SELL
$12.83 - $42.25 $701,749 - $2.31 Million
-54,696 Reduced 79.45%
14,151 $335,000
Q1 2021

Jun 26, 2023
SELL
$12.83 - $42.25 $35,218 - $115,976
-2,745 Reduced 16.25%
14,151 $336 Million
Q1 2021

Mar 22, 2023
SELL
$12.83 - $42.25 $383,719 - $1.26 Million
-29,908 Reduced 67.88%
14,151 $335,000
Q1 2021

May 14, 2021
BUY
$12.83 - $42.25 $181,557 - $597,879
14,151 New
14,151 $336,000

Others Institutions Holding IBRX

# of Institutions
229
Shares Held
82.3M
Call Options Held
1.02M
Put Options Held
2.25M
View Full List

About ImmunityBio, Inc.

IBRX Quotes by TradingView
  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.08B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email